Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will TRIPLE your donation, which means it’ll go 3x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets tripled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Pfizer-BioNTech COVID-19 Vaccine Rolls Out Across the U.S. as Death Toll Tops 300,000

HeadlineDec 14, 2020

The first shipments of the Pfizer-BioNTech COVID-19 vaccine are arriving in all 50 states today after the Food and Drug Administration issued an emergency use authorization late Friday. The vaccine is being deployed as the U.S. tops 300,000 recorded deaths from COVID-19 today, with confirmed cases topping 16.2 million — by far the highest numbers in the world. The first shipment will cover some 3 million people. Healthcare workers will receive the first doses this week, followed by nursing home residents and staff. FDA Commissioner Stephen Hahn said Sunday he hoped the first doses would be administered today. He also denied reports he was threatened by President Trump Friday to approve the vaccine quickly, saying the authorization was based on “a thorough review of the science and data.”

Meanwhile, the coronavirus vaccine developed by Moderna is likely to be approved by the end of the week, according to Operation Warp Speed chief adviser Moncef Slaoui. The U.S. government purchased another 100 million doses of the Moderna vaccine last week, which the Trump administration said would ensure continuous vaccine delivery through the end of June 2021.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation